Drug Profile
Research programme: endomorphin analogues - Cytogel Pharma
Alternative Names: EM-1; Endomorphin-1Latest Information Update: 28 Oct 2022
Price :
$50
*
At a glance
- Originator Tulane University
- Developer Cytogel
- Class Analgesics; Peptides
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Pain